Colecalciferol with calcium carbonate
Brand names: Adcal-D3, Calcichew-D3, Accrete D3
A combined oral supplement of colecalciferol (vitamin D3) with calcium carbonate, used to treat or prevent vitamin D and calcium deficiency, including as adjunct to osteoporosis therapy.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Colecalciferol is converted in the liver and kidney to active calcitriol, which enhances intestinal calcium absorption, while calcium carbonate provides elemental calcium as substrate for bone mineralisation.
Prescribing in practice
- The most important safety point is the risk of hypercalcaemia and hypercalciuria, so it should be avoided in conditions predisposing to high calcium and used cautiously with other vitamin D or calcium products.
- Calcium carbonate reduces absorption of several drugs, notably oral bisphosphonates, levothyroxine, and certain antibiotics, which should be separated in time.
- Use with caution in renal impairment and in patients with a history of renal stones or sarcoidosis.
Monitoring
Monitor serum calcium (and renal function where relevant), particularly in those on high doses or with impaired renal function.
Counselling the patient
- Take any bisphosphonate, levothyroxine, or relevant antibiotic at a separate time from this supplement.
- Report symptoms such as nausea, thirst, constipation, or confusion that could indicate too much calcium.
Evidence & guidelines
Combined calcium and vitamin D supplementation is supported by NICE and NOGG guidance as adjunctive therapy alongside bone-protective treatment in osteoporosis.
Reference: NICE NG56; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Hyperkalaemia Management Algorithm · Electrolyte Disorders
- FAST Exam Protocol — Focused Assessment with Sonography in Trauma · Trauma
- Corrected Calcium · Electrolytes
- Calcium-Phosphate Product · Electrolytes
- Corrected Calcium (for Albumin) · Electrolytes
- Hyperkalaemia Severity and ECG Risk · Electrolytes
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016